Adapt Wealth Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Adapt Wealth Advisors's LLY Position: Q1 2026 in Review
Adapt Wealth Advisors reduced its Eli Lilly (LLY) stake by 3.9% in Q1 2026, selling an estimated $62.9K and leaving 1,524 shares worth $1.4M. The position accounts for 0.51% of the portfolio, ranked #36.
Adapt Wealth Advisors first reported a position in LLY in Q1 2024 and has held it in 9 quarters since. The position peaked at $1.7M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Adapt Wealth Advisors held 1,524 shares of Eli Lilly worth $1.4M as of Q1 2026.
- Adapt Wealth Advisors sold 62 Eli Lilly shares in Q1 2026, an estimated $62.9K.
- Eli Lilly made up 0.51% of Adapt Wealth Advisors's portfolio in Q1 2026, its #36 holding.
- Adapt Wealth Advisors first reported a position in Eli Lilly in Q1 2024 and has held it in 9 quarters since.
- Adapt Wealth Advisors's Eli Lilly position peaked at $1.7M in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Adapt Wealth Advisors's 13F filing for Q1 2026, filed 11 May 2026.